Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma

The investigators aim at investigating in a prospective clinical trial whether using a Simoultaneous Integrated Boost of carbon ions treatment planning approach, improving the tumor dose conformation while lowering the unintended dose to the low-risk volume, can significantly reduce the probability of toxicity without affecting Local Control.

Trial Details

NCT ID
NCT05733910
Phase
NA
Sponsor
CNAO National Center of Oncological Hadrontherapy
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • simultaneous integrated boost of carbon ions radiation therapy
Locations (sample)
  • Pavia, Pavia, Italy|45.19205,9.15917

Key Eligibility Criteria

  • Histologically-proven primary head and neck ACC;
  • Unresectable stage or residual macroscopic disease after surgery or multiple microscopic margins after surgery;
  • Patient with resectable tumor but refusing surgery
  • cN0/pN0 - cN1/pN1 patients (only ipsilateral neck levels I and II)

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →